Amgen Inc (AMGN)

pos +0.00
Today's Range: 0.00 - 0.00 | AMGN Avg Daily Volume: 2,732,600
Last Update: 10/26/16 - 4:00 PM EDT
Volume: 0
YTD Performance: -2.06%
Open: $0.00
Previous Close: $158.99
52 Week Range: $139.02 - $176.85
Oustanding Shares: 748,360,906
Market Cap: 118,166,187,057
6-Month Chart
TheStreet Ratings Grade for AMGN
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 4 4 4 4
Moderate Buy 1 1 1 2
Hold 11 10 10 10
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.41 2.37 2.37 2.34
Latest Dividend: 1.00
Latest Dividend Yield: 2.53%
Dividend Ex-Date: 11/14/16
Price Earnings Ratio: 14.24
Price Earnings Comparisons:
AMGN Sector Avg. S&P 500
14.24 16.70 29.40
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-5.18% 0.26% 36.68%
Revenue 8.00 0.20 0.08
Net Income 34.50 0.60 0.17
EPS 35.20 0.60 0.18
Earnings for AMGN:
Revenue 21.66B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $2.79 $2.79 $11.34 $12.33
Number of Analysts 12 10 14 14
High Estimate $3.01 $3.03 $11.77 $14.10
Low Estimate $2.58 $2.64 $11.10 $11.15
Prior Year $2.72 $2.61 $10.38 $11.34
Growth Rate (Year over Year) 2.73% 6.93% 9.25% 8.74%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
AMGN is neutral now, but a close below $158 weakens the chart picture.
Both it and Ligand Pharmaceuticals look significantly undervalued relative to their prospects.
The once-mighty biotech has fallen, but entry opportunities will surface.
The shares have some power and legs to get up and through old highs.
These stocks look good as seasonal volatility sets in.
Often, pictures speak louder than words.
Las Vegas Sands (LVS) continues to show strength after Bank of America/Merrill Lynch put out an optimistic note this morning about Macau gambling. Energy is weak in early trading. Oil has drifted back down to around $47 a barrel following its recent roughly 20% rally.
RBC Capital analysts say splitting the company into two distinct businesses would free 'trapped value' on drug treatments.
These are the biggest errors that I've made over the years.
These sectors offer value as the S&P 500 trades at 19x earnings.

Columnist Conversations

Raytheon is building on Tuesday's impressive breakout.  The defense name is up over 1.25% ahead of tonigh...
Merck had a nice earnings beat on Tuesday which was accompanied by an earlier than expected FDA approval on Ke...
For years Apple was accused of under promise, over deliver --- UPOD as Jim Cramer likes to call it.  Whil...
Market down across the board, as less than optimistic outlook from Apple (AAPL) dampens investor enthusiasm in...


News Breaks

Powered by


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.